Related Experiment Video
Updated: Jun 28, 2026

Formaldehyde-assisted Isolation of Regulatory Elements to Measure Chromatin Accessibility in Mammalian Cells
Published on: April 2, 2018
Casein kinase II is a negative regulator of c-Jun DNA binding and AP-1 activity
1Department of Pharmacology, University of California, San Diego School of Medicine, La Jolla 92093-0636.
Abstract:
c-Jun, a major component of the inducible transcription factor AP-1, is a phosphoprotein. In nonstimulated fibroblasts and epithelial cells, c-Jun is phosphorylated on a cluster of two to three sites abutting its DNA-binding domain. Phosphorylation of these sites inhibits DNA binding, and their dephosphorylation correlates with increased AP-1 activity. We show that two of these sites, Thr-231 and Ser-249, are phosphorylated by casein kinase II (CKII). Substitution of the third site, Ser-243, by Phe interferes with phosphorylation of the inhibitory sites in vivo and by purified CKII in vitro. Microinjection into living cells of synthetic peptides that are specific competitive substrates or inhibitors of CKII results in induction of AP-1 activity and c-Jun expression. Microinjection of CKII suppresses induction of AP-1 by either phorbol ester or an inhibitory peptide. These results suggest that one of the roles of CKII, a major nuclear protein kinase with no known functions, is to attenuate AP-1 activity through phosphorylation of c-Jun.
Insights
Casein kinase II (CKII) phosphorylates c-Jun, inhibiting its DNA binding and AP-1 activity. This study reveals CKII
Area of Science:
- Molecular Biology
- Cell Signaling
- Biochemistry
Background:
- c-Jun is a key component of the AP-1 transcription factor, regulating gene expression.
- Phosphorylation of c-Jun inhibits its DNA-binding activity, impacting AP-1 transcriptional function.
- The specific kinases responsible for c-Jun phosphorylation and their regulatory roles were not fully understood.
Purpose of the Study:
- To identify the kinase responsible for phosphorylating inhibitory sites on c-Jun.
- To elucidate the role of casein kinase II (CKII) in regulating AP-1 activity.
- To investigate how CKII-mediated phosphorylation of c-Jun affects AP-1 transcriptional function.
Main Methods:
- Site-directed mutagenesis of c-Jun phosphorylation sites.
- In vitro kinase assays using purified casein kinase II.
- In vivo studies involving microinjection of peptides and CKII into cells.
- Analysis of AP-1 activity and c-Jun expression levels.
Main Results:
- Casein kinase II (CKII) was identified as the kinase phosphorylating Thr-231 and Ser-249 on c-Jun.
- Substitution of Ser-243 with Phenylalanine impaired c-Jun phosphorylation by CKII.
- Microinjection of CKII inhibitors induced AP-1 activity and c-Jun expression.
- Microinjection of CKII suppressed AP-1 induction by phorbol ester or inhibitory peptides.
Conclusions:
- Casein kinase II (CKII) plays a crucial role in attenuating AP-1 activity by phosphorylating c-Jun.
- CKII acts as a negative regulator of AP-1 transcriptional activity.
- These findings uncover a novel function for CKII in cellular signaling pathways.
More Related Videos
09:52A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
RNA Polymerase II Accessory Proteins
Co-activators and Co-repressors
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
RNA Polymerase II Accessory Proteins
Co-activators and Co-repressors
MAPK Signaling Cascades